Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Fermented Dairy Foods: Impact on Intestinal Microbiota and Health-Linked Biomarkers.

González S, Fernández-Navarro T, Arboleya S, de Los Reyes-Gavilán CG, Salazar N, Gueimonde M.

Front Microbiol. 2019 May 24;10:1046. doi: 10.3389/fmicb.2019.01046. eCollection 2019.

2.

Intestinal Immunomodulation and Shifts on the Gut Microbiota of BALB/c Mice Promoted by Two Bifidobacterium and Lactobacillus Strains Isolated from Human Samples.

Nogacka AM, Oddi S, Salazar N, Reinheimer JA, Gueimonde M, Vinderola G, de Los Reyes-Gavilán CG.

Biomed Res Int. 2019 Apr 18;2019:2323540. doi: 10.1155/2019/2323540. eCollection 2019.

3.

Exploring the interactions between serum free fatty acids and fecal microbiota in obesity through a machine learning algorithm.

Fernández-Navarro T, Díaz I, Gutiérrez-Díaz I, Rodríguez-Carrio J, Suárez A, de Los Reyes-Gavilán CG, Gueimonde M, Salazar N, González S.

Food Res Int. 2019 Jul;121:533-541. doi: 10.1016/j.foodres.2018.12.009. Epub 2018 Dec 5.

PMID:
31108778
4.

Reply: "Letter to the editor Re: Diaz M., et al. Nutrients 2018, 10, 1481".

Díaz M, Guadamuro L, Espinosa-Martos I, Mancabelli L, Jiménez S, Molinos-Norniella C, Pérez-Solis D, Milani C, Rodríguez JM, Ventura M, Bousoño C, Gueimonde M, Margolles A, Díaz JJ, Delgado S.

Nutrients. 2019 Feb 24;11(2). pii: E476. doi: 10.3390/nu11020476.

5.

Impact of probiotics on development and behaviour in Drosophila melanogaster - a potential in vivo model to assess probiotics.

Gómez E, Martín F, Nogacka AM, Salazar N, Aláez L, Alcorta E, Gueimonde M, De Los Reyes-Gavilán CG.

Benef Microbes. 2019 Mar 13;10(2):179-188. doi: 10.3920/BM2018.0012. Epub 2018 Dec 21.

PMID:
30574803
6.

The role of yogurt in food-based dietary guidelines.

Gómez-Gallego C, Gueimonde M, Salminen S.

Nutr Rev. 2018 Dec 1;76(Supplement_1):29-39. doi: 10.1093/nutrit/nuy059.

PMID:
30452698
7.

Microbiota and Derived Parameters in Fecal Samples of Infants with Non-IgE Cow's Milk Protein Allergy under a Restricted Diet.

Díaz M, Guadamuro L, Espinosa-Martos I, Mancabelli L, Jiménez S, Molinos-Norniella C, Pérez-Solis D, Milani C, Rodríguez JM, Ventura M, Bousoño C, Gueimonde M, Margolles A, Díaz JJ, Delgado S.

Nutrients. 2018 Oct 11;10(10). pii: E1481. doi: 10.3390/nu10101481.

8.

Fecal microbiota profile in a group of myasthenia gravis patients.

Moris G, Arboleya S, Mancabelli L, Milani C, Ventura M, de Los Reyes-Gavilán CG, Gueimonde M.

Sci Rep. 2018 Sep 26;8(1):14384. doi: 10.1038/s41598-018-32700-y.

9.

Could Fecal Phenylacetic and Phenylpropionic Acids Be Used as Indicators of Health Status?

Gutiérrez-Díaz I, Fernández-Navarro T, Salazar N, Bartolomé B, Moreno-Arribas MV, López P, Suárez A, de Los Reyes-Gavilán CG, Gueimonde M, González S.

J Agric Food Chem. 2018 Oct 10;66(40):10438-10446. doi: 10.1021/acs.jafc.8b04102. Epub 2018 Sep 28.

PMID:
30227707
10.

C-section and the Neonatal Gut Microbiome Acquisition: Consequences for Future Health.

Arboleya S, Suárez M, Fernández N, Mantecón L, Solís G, Gueimonde M, de Los Reyes-Gavilán CG.

Ann Nutr Metab. 2018;73 Suppl 3:17-23. doi: 10.1159/000490843. Epub 2018 Jul 24. Review.

11.

Real-time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups.

Nogacka AM, Ruas-Madiedo P, Gómez E, Solís G, Fernández N, Suárez M, Suárez A, Salazar N, de Los Reyes-Gavilán CG, Gueimonde M.

J Microbiol Methods. 2018 Sep;152:210-216. doi: 10.1016/j.mimet.2018.07.003. Epub 2018 Jul 10.

PMID:
30006229
12.

Probiotics for Prevention and Treatment of Clostridium difficile Infection.

Valdés-Varela L, Gueimonde M, Ruas-Madiedo P.

Adv Exp Med Biol. 2018;1050:161-176. doi: 10.1007/978-3-319-72799-8_10. Review.

PMID:
29383669
13.

Bifidobacterium breve IPLA20005 affects in vitro the expression of hly and luxS genes, related to the virulence of Listeria monocytogenes Lm23.

Rios-Covian D, Nogacka A, Salazar N, Hernández-Barranco AM, Cuesta I, Gueimonde M, de Los Reyes Gavilán CG.

Can J Microbiol. 2018 Mar;64(3):215-221. doi: 10.1139/cjm-2017-0625. Epub 2018 Jan 3.

PMID:
29298396
14.

Transmission and persistence of IncF conjugative plasmids in the gut microbiota of full-term infants.

Ravi A, Valdés-Varela L, Gueimonde M, Rudi K.

FEMS Microbiol Ecol. 2018 Jan 1;94(1). doi: 10.1093/femsec/fix158.

PMID:
29161377
15.

The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, Belzer C, Delgado Palacio S, Arboleya Montes S, Mancabelli L, Lugli GA, Rodriguez JM, Bode L, de Vos W, Gueimonde M, Margolles A, van Sinderen D, Ventura M.

Microbiol Mol Biol Rev. 2017 Nov 8;81(4). pii: e00036-17. doi: 10.1128/MMBR.00036-17. Print 2017 Dec. Review.

16.

Early microbiota, antibiotics and health.

Nogacka AM, Salazar N, Arboleya S, Suárez M, Fernández N, Solís G, de Los Reyes-Gavilán CG, Gueimonde M.

Cell Mol Life Sci. 2018 Jan;75(1):83-91. doi: 10.1007/s00018-017-2670-2. Epub 2017 Oct 7. Review.

PMID:
28988290
17.

Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union.

Brodmann T, Endo A, Gueimonde M, Vinderola G, Kneifel W, de Vos WM, Salminen S, Gómez-Gallego C.

Front Microbiol. 2017 Sep 12;8:1725. doi: 10.3389/fmicb.2017.01725. eCollection 2017. Review.

18.

Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids.

Rodríguez-Carrio J, Salazar N, Margolles A, González S, Gueimonde M, de Los Reyes-Gavilán CG, Suárez A.

Front Immunol. 2017 Jul 24;8:823. doi: 10.3389/fimmu.2017.00823. eCollection 2017.

19.

Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates.

Nogacka A, Salazar N, Suárez M, Milani C, Arboleya S, Solís G, Fernández N, Alaez L, Hernández-Barranco AM, de Los Reyes-Gavilán CG, Ventura M, Gueimonde M.

Microbiome. 2017 Aug 8;5(1):93. doi: 10.1186/s40168-017-0313-3.

20.

Different Intestinal Microbial Profile in Over-Weight and Obese Subjects Consuming a Diet with Low Content of Fiber and Antioxidants.

Fernández-Navarro T, Salazar N, Gutiérrez-Díaz I, de Los Reyes-Gavilán CG, Gueimonde M, González S.

Nutrients. 2017 May 27;9(6). pii: E551. doi: 10.3390/nu9060551.

21.

Shaping the Metabolism of Intestinal Bacteroides Population through Diet to Improve Human Health.

Rios-Covian D, Salazar N, Gueimonde M, de Los Reyes-Gavilan CG.

Front Microbiol. 2017 Mar 7;8:376. doi: 10.3389/fmicb.2017.00376. eCollection 2017. No abstract available.

22.

Intestinal Microbiota and Weight-Gain in Preterm Neonates.

Arboleya S, Martinez-Camblor P, Solís G, Suárez M, Fernández N, de Los Reyes-Gavilán CG, Gueimonde M.

Front Microbiol. 2017 Feb 8;8:183. doi: 10.3389/fmicb.2017.00183. eCollection 2017.

23.

Intestinal Dysbiosis Is Associated with Altered Short-Chain Fatty Acids and Serum-Free Fatty Acids in Systemic Lupus Erythematosus.

Rodríguez-Carrio J, López P, Sánchez B, González S, Gueimonde M, Margolles A, de Los Reyes-Gavilán CG, Suárez A.

Front Immunol. 2017 Jan 23;8:23. doi: 10.3389/fimmu.2017.00023. eCollection 2017.

24.

Adherence to a Mediterranean Diet Influences the Fecal Metabolic Profile of Microbial-Derived Phenolics in a Spanish Cohort of Middle-Age and Older People.

Gutiérrez-Díaz I, Fernández-Navarro T, Salazar N, Bartolomé B, Moreno-Arribas MV, de Andres-Galiana EJ, Fernández-Martínez JL, de Los Reyes-Gavilán CG, Gueimonde M, González S.

J Agric Food Chem. 2017 Jan 25;65(3):586-595. doi: 10.1021/acs.jafc.6b04408. Epub 2017 Jan 11.

PMID:
28029051
25.

In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations.

Valdés-Varela L, Ruas-Madiedo P, Gueimonde M.

Int J Food Microbiol. 2017 Feb 2;242:19-23. doi: 10.1016/j.ijfoodmicro.2016.11.011. Epub 2016 Nov 12.

PMID:
27866040
26.

Nutrition and the gut microbiome in the elderly.

Salazar N, Valdés-Varela L, González S, Gueimonde M, de Los Reyes-Gavilán CG.

Gut Microbes. 2017 Mar 4;8(2):82-97. doi: 10.1080/19490976.2016.1256525. Epub 2016 Nov 3. Review.

27.

Bioactive compounds from regular diet and faecal microbial metabolites.

Fernández-Navarro T, Salazar N, Gutiérrez-Díaz I, Sánchez B, Rúas-Madiedo P, de Los Reyes-Gavilán CG, Margolles A, Gueimonde M, González S.

Eur J Nutr. 2018 Mar;57(2):487-497. doi: 10.1007/s00394-016-1332-8. Epub 2016 Oct 15.

PMID:
27744545
28.

Probiotics, gut microbiota, and their influence on host health and disease.

Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M, Margolles A.

Mol Nutr Food Res. 2017 Jan;61(1). doi: 10.1002/mnfr.201600240. Epub 2016 Oct 10. Review.

PMID:
27500859
29.

Bacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria.

Rios-Covian D, Cuesta I, Alvarez-Buylla JR, Ruas-Madiedo P, Gueimonde M, de Los Reyes-Gavilán CG.

BMC Microbiol. 2016 Jul 15;16(1):150. doi: 10.1186/s12866-016-0773-9.

30.

Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates.

Valdés-Varela L, Hernández-Barranco AM, Ruas-Madiedo P, Gueimonde M.

Front Microbiol. 2016 May 18;7:738. doi: 10.3389/fmicb.2016.00738. eCollection 2016.

31.

A proteomic approach towards understanding the cross talk between Bacteroides fragilis and Bifidobacterium longum in coculture.

Rios-Covián D, Sánchez B, Martínez N, Cuesta I, Hernández-Barranco AM, de Los Reyes-Gavilán CG, Gueimonde M.

Can J Microbiol. 2016 Jul;62(7):623-8. doi: 10.1139/cjm-2015-0804. Epub 2016 Mar 4.

PMID:
27156738
32.

Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer.

Valdés-Varela L, Alonso-Guervos M, García-Suárez O, Gueimonde M, Ruas-Madiedo P.

Front Microbiol. 2016 Apr 22;7:577. doi: 10.3389/fmicb.2016.00577. eCollection 2016.

33.

Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study.

Arboleya S, Sánchez B, Solís G, Fernández N, Suárez M, Hernández-Barranco AM, Milani C, Margolles A, de Los Reyes-Gavilán CG, Ventura M, Gueimonde M.

Int J Mol Sci. 2016 Apr 29;17(5). pii: E649. doi: 10.3390/ijms17050649.

34.

Perinatal Microbiomes' Influence on Preterm Birth and Preterms' Health: Influencing Factors and Modulation Strategies.

Ruiz L, Moles L, Gueimonde M, Rodriguez JM.

J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):e193-e203. Review.

PMID:
27019409
35.

Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health.

Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N.

Front Microbiol. 2016 Feb 17;7:185. doi: 10.3389/fmicb.2016.00185. eCollection 2016. Review.

36.

Supplementation of xylitol-containing chewing gum with probiotics: a double blind, randomised pilot study focusing on saliva flow and saliva properties.

Gueimonde L, Vesterlund S, García-Pola MJ, Gueimonde M, Söderling E, Salminen S.

Food Funct. 2016 Mar;7(3):1601-9. doi: 10.1039/c5fo01497b.

PMID:
26913493
37.

Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis.

Hevia A, Milani C, López P, Donado CD, Cuervo A, González S, Suárez A, Turroni F, Gueimonde M, Ventura M, Sánchez B, Margolles A.

PLoS One. 2016 Feb 3;11(2):e0147809. doi: 10.1371/journal.pone.0147809. eCollection 2016.

38.

Glucolytic fingerprinting reveals metabolic groups within the genus Bifidobacterium: an exploratory study.

Rios-Covián D, Sánchez B, Cuesta I, Cueto-Díaz S, Hernández-Barranco AM, Gueimonde M, De los Reyes-Gavilán CG.

Benef Microbes. 2016;7(2):265-73. doi: 10.3920/BM2015.0129. Epub 2016 Feb 3.

PMID:
26839073
39.

Monitoring in real time the cytotoxic effect of Clostridium difficile upon the intestinal epithelial cell line HT29.

Valdés L, Gueimonde M, Ruas-Madiedo P.

J Microbiol Methods. 2015 Dec;119:66-73. doi: 10.1016/j.mimet.2015.09.022. Epub 2015 Oct 5.

PMID:
26436983
40.

Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis.

Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG.

FEMS Microbiol Lett. 2015 Nov;362(21). pii: fnv176. doi: 10.1093/femsle/fnv176. Epub 2015 Sep 28.

PMID:
26420851
41.

Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria.

Rios-Covian D, Sánchez B, Salazar N, Martínez N, Redruello B, Gueimonde M, de Los Reyes-Gavilán CG.

Front Microbiol. 2015 Aug 18;6:825. doi: 10.3389/fmicb.2015.00825. eCollection 2015.

42.

Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.

Briner AE, Lugli GA, Milani C, Duranti S, Turroni F, Gueimonde M, Margolles A, van Sinderen D, Ventura M, Barrangou R.

PLoS One. 2015 Jul 31;10(7):e0133661. doi: 10.1371/journal.pone.0133661. eCollection 2015.

43.

Capability of exopolysaccharide-producing Lactobacillus paraplantarum BGCG11 and its non-producing isogenic strain NB1, to counteract the effect of enteropathogens upon the epithelial cell line HT29-MTX.

Zivkovic M, Hidalgo-Cantabrana C, Kojic M, Gueimonde M, Golic N, Ruas-Madiedo P.

Food Res Int. 2015 Aug;74:199-207. doi: 10.1016/j.foodres.2015.05.012. Epub 2015 May 12.

PMID:
28411984
44.

The relationship between phenolic compounds from diet and microbiota: impact on human health.

Valdés L, Cuervo A, Salazar N, Ruas-Madiedo P, Gueimonde M, González S.

Food Funct. 2015 Aug;6(8):2424-39. doi: 10.1039/c5fo00322a. Epub 2015 Jun 11. Review.

PMID:
26068710
45.

Intestinal microbiota as modulators of the immune system.

Sánchez B, Gueimonde M, Peña AS, Bernardo D.

J Immunol Res. 2015;2015:159094. doi: 10.1155/2015/159094. Epub 2015 Mar 2. No abstract available.

46.

The effects of Bifidobacterium breve on immune mediators and proteome of HT29 cells monolayers.

Sánchez B, González-Rodríguez I, Arboleya S, López P, Suárez A, Ruas-Madiedo P, Margolles A, Gueimonde M.

Biomed Res Int. 2015;2015:479140. doi: 10.1155/2015/479140. Epub 2015 Feb 22.

47.

Red wine consumption is associated with fecal microbiota and malondialdehyde in a human population.

Cuervo A, Reyes-Gavilán CG, Ruas-Madiedo P, Lopez P, Suarez A, Gueimonde M, González S.

J Am Coll Nutr. 2015;34(2):135-41. doi: 10.1080/07315724.2014.904763. Epub 2015 Mar 4.

PMID:
25738317
48.

Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota.

Arboleya S, Bahrami B, Macfarlane S, Gueimonde M, Macfarlane GT, de los Reyes-Gavilán CG.

Benef Microbes. 2015;6(4):543-52. doi: 10.3920/BM2014.0111. Epub 2015 Apr 22.

PMID:
25691102
49.

Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota.

Salazar N, Gueimonde M, de Los Reyes-Gavilán CG, Ruas-Madiedo P.

Crit Rev Food Sci Nutr. 2016 Jul 3;56(9):1440-53. doi: 10.1080/10408398.2013.770728. Review.

PMID:
25675369
50.

Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum.

Duranti S, Milani C, Lugli GA, Turroni F, Mancabelli L, Sanchez B, Ferrario C, Viappiani A, Mangifesta M, Mancino W, Gueimonde M, Margolles A, van Sinderen D, Ventura M.

Environ Microbiol. 2015 Jul;17(7):2515-31. doi: 10.1111/1462-2920.12743. Epub 2015 Feb 14.

PMID:
25523018

Supplemental Content

Loading ...
Support Center